发明名称 |
Composition containing murine embryonic stem cells, useful for administration to primates to treat e.g. cardiac diseases, hepatitis, diabetes or neurodegeneration |
摘要 |
<p>A composition (A) comprising murine embryonal stem cells (ESC) intended for therapeutic use in primates, is new. A composition (A) comprising murine embryonal stem cells (ESC) intended for therapeutic use in primates. The composition is obtained by in vitro maintaining of the undifferentiated cell of the mouse in a culture medium with a compound, in vitro culturing of the undifferentiated cells without the compound and purifying the cells by negative selection of an antibody/ligand specifically directed against a specific marker of the undifferentiated cells or by positive selection using an antibody/ligand specifically directed against a specific marker of a phenotype of the initiated cells. The cells are engaged in the differentiation way in neurons, hematopoietic cells, osteogenic cells, chondrocytes, spinal cord, oligodendrocytes or precursors of the cell line. ACTIVITY : Cardiant; Hepatotropic; Cytostatic; Antiinflammatory; Antidiabetic; Neuroprotective; Osteopathic; Antiarthritic; Nootropic; Antiparkinsonian; Anticonvulsant; Vulnerary; Dermatological. No biological data given. MECHANISM OF ACTION : Cell and tissue replacement.</p> |
申请公布号 |
FR2884146(A1) |
申请公布日期 |
2006.10.13 |
申请号 |
FR20050003474 |
申请日期 |
2005.04.07 |
申请人 |
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS ETABLISSEMENT PUBLIC |
发明人 |
MENASCHE PHILIPPE;HAGEGE ALBERT;DESNOS MICHEL;PUCEAT MICHEL;MENARD CLAUDINE |
分类号 |
A61K35/54;A61P1/00;A61P5/50;A61P7/00;A61P9/04;A61P19/00;A61P25/00;C12N5/0735;C12N5/077 |
主分类号 |
A61K35/54 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|